In this follow-up report, the relationship between total anti–Ebola virus (EBOV) and EBOV neutralizing-antibody concentrations, in convalescent plasma used in the treatment of Ebola disease, was ...

The Ebola virus (EBOV) causes severe inflammation and tissue damage throughout the body, affecting the natural blood clotting mechanism, leading to internal bleeding, and ultimately death with ...

Two of the more prominent examples are Zika virus (ZIKV) and Ebola virus (EBOV), which have been found in symptomatically infected patients and disease survivors. 1,2 Contrary to prevalent belief ...

BOMV-ZsG and EBOV-ZsG infection was also prevented by Remdesivir, with EC50 values of 17nM and 6nM, respectively. The authors tested the ability of mAbs produced to target the EBOV glycoprotein to ...

And while evidence suggests that EBOV can be passed on from skin contact with a person in the later stages of the disease, very little is known about how the virus makes its way out of the body ...

Researchers have traced a cellular route Ebola virus (EBOV) uses to traverse the inner and outer layers of skin and emerge onto the skin's surface. The study identifies new cell types within the ...

All SK inhibitors prevented EBOV from trafficking to late-endosomes and/or lysosomes containing NPC1, indicating that SKs play critical roles in endosomal trafficking.

RedHill Biopharma Logo. Under this cost-sharing contract, BARDA will provide partial funding for the company to further advance opaganib to mitigate infection and contain EBOV outbreaks.

EBOV has claimed the lives of over 4,000 people. The first fatality on American soil was recorded earlier this month in Dallas, Texas. The virus claimed the life of Thomas Eric Duncan, ...

Dubbed Ad5-EBOV, the recombinant adenovirus vector-based vaccine is the first shot based on the strain behind the recent epidemic in West Africa in 2014—the deadliest outbreak in recorded history.